masoprocol has been researched along with Glioma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, XW; Cui, YH; Lin, Y; Xu, CR; Yao, YL; Zhang, X; Zhao, QW | 1 |
| Bian, X; Chen, G; Cui, W; Cui, Y; Gu, A; Li, T; Xu, C; Yang, X; Yu, S; Zhang, X | 1 |
| Bian, XW; Cui, YH; Jiang, JY; Ping, YF; Porter, GW; Qian, C; Tan, H; Wang, B; Wang, Z; Yu, SC; Zhao, LT | 1 |
| Desideri, S; Grossman, SA; Mikkelsen, T; Peereboom, D; Rosenfeld, MR; Supko, JG; Ye, X | 1 |
| Bai, JS; Bian, XW; Chen, JH; Dai, C; Jiang, XF; Liu, MY; Lu, JY; Shi, JQ; Wang, JM; Wang, QL; Xin, R; Zhao, W | 1 |
| Bian, XW; Chen, JH; Chen, K; Gong, W; Hu, J; Iribarren, P; Yao, XH; Zhao, W; Zhou, XD | 1 |
| Bian, XW; Chen, JH; Chen, K; Gong, W; Hu, J; Liu, H; Ping, YF; Wang, JM; Yao, XH; Zhou, XD | 1 |
| Bian, XW; Chen, DL; Chen, JH; Liu, H; Ping, YF; Wang, JM; Yao, XH; Zhou, XD | 1 |
| Bian, XW; Chen, JH; Jiang, XF; Ping, YF; Wang, QL; Yao, XH | 1 |
| Hsu, SP; Huang, CN; Peng, CH; Wang, CJ | 1 |
| Bian, XW; Chen, JH; Chen, YS; Ping, YF; Shi, JQ; Wang, JM; Wang, Y; Wu, J; Wu, YZ; Xu, CP; Xu, JP; Zhou, XD | 1 |
| Dichgans, J; Gulbins, E; Lang, F; Wagenknecht, B; Weller, M | 1 |
| Gulbins, E; Schulz, JB; Wagenknecht, B; Weller, M | 1 |
| Guan, Z; Saqr, HE; Stokes, BT; Yates, AJ | 1 |
| Chang, HJ; Chang, HT; Chen, WC; Cheng, JS; Chou, KJ; Jan, CR; Lee, KC; Lin, MC; Liu, CP; Lo, YK; Su, W; Tseng, LL; Wang, JL | 1 |
| Bergström, M; Carlsson, J; Csòka, K; Gàti, I; Muhr, C; Westerberg, G | 1 |
| Anderson, KM; Seed, TM; Wilson, DE | 1 |
| Anderson, KM; DiGianfilippo, A; Harris, JE; Ondrey, FG; Wilson, DE | 1 |
1 trial(s) available for masoprocol and Glioma
| Article | Year |
|---|---|
Phase I study of terameprocol in patients with recurrent high-grade glioma.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Glioma; Humans; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2012 |
17 other study(ies) available for masoprocol and Glioma
| Article | Year |
|---|---|
NDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Masoprocol | 2017 |
A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Glycoproteins; Humans; Masoprocol; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays; Zebrafish | 2014 |
An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Arachidonate 5-Lipoxygenase; Astrocytes; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Female; Glial Fibrillary Acidic Protein; Glioma; Glycoproteins; Homeodomain Proteins; Humans; Intermediate Filament Proteins; Ki-67 Antigen; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; Mice; Mice, Nude; Nanog Homeobox Protein; Neoplasm Transplantation; Neoplastic Stem Cells; Nerve Tissue Proteins; Nestin; Octamer Transcription Factor-3; Peptides; Protein Serine-Threonine Kinases; SOXB1 Transcription Factors; Transplantation, Heterologous; Tumor Burden | 2011 |
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Cell Line; Cells, Cultured; Endothelium, Vascular; Glioblastoma; Glioma; Humans; Immunomagnetic Separation; In Vitro Techniques; Lignans; Masoprocol; Microcirculation; Models, Biological; Neovascularization, Pathologic; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2006 |
Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioma; Humans; Lignans; Lipoxygenase Inhibitors; Masoprocol; Rats; Receptors, Formyl Peptide | 2006 |
A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Calcium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Gene Expression; Glioma; Humans; Intercellular Signaling Peptides and Proteins; Lipoxygenase Inhibitors; Masoprocol; Mice; Neoplasms, Experimental; Receptors, Formyl Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
Topics: Analysis of Variance; Angiogenic Proteins; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-8; Lignans; Lipoxygenase Inhibitors; Masoprocol; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, CXCR4; RNA, Messenger; Vascular Endothelial Growth Factor A | 2007 |
[Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme-Linked Immunosorbent Assay; Glioma; Humans; Interleukin-8; Masoprocol; Microscopy, Confocal; N-Formylmethionine Leucyl-Phenylalanine; Receptors, Formyl Peptide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2007 |
Penta-acetyl geniposide-induced apoptosis involving transcription of NGF/p75 via MAPK-mediated AP-1 activation in C6 glioma cells.
Topics: Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cell Line, Tumor; Electrophoretic Mobility Shift Assay; Flavonoids; Gardenia; Glioma; Glucosides; Imidazoles; Immunoblotting; Iridoid Glucosides; Iridoids; Keratolytic Agents; Masoprocol; Mitogen-Activated Protein Kinases; Molecular Structure; Nerve Growth Factor; NF-kappa B; Peptide Fragments; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation | 2007 |
Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Lipoxygenase Inhibitors; Masoprocol; Mice; Molecular Sequence Data; Xenograft Model Antitumor Assays | 2008 |
Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.
Topics: Animals; Apoptosis; Arachidonic Acid; Fas Ligand Protein; fas Receptor; Glioma; Humans; Ligands; Lipoxygenase Inhibitors; Masoprocol; Membrane Glycoproteins; Mice; Phospholipases; Tumor Cells, Cultured | 1997 |
Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
Topics: Animals; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Survival; Ceramides; Cycloheximide; Cysteine Proteinase Inhibitors; Enzyme Activation; Fas Ligand Protein; fas Receptor; Glioma; Humans; Masoprocol; Membrane Glycoproteins; Mice; Proto-Oncogene Proteins c-bcl-2; Serpins; Signal Transduction; Transfection; Tumor Cells, Cultured; Viral Proteins | 1998 |
Mechanisms through which PDGF alters intracellular calcium levels in U-1242 MG human glioma cells.
Topics: Becaplermin; Brain Neoplasms; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Calcium-Transporting ATPases; Elapid Venoms; Endoplasmic Reticulum; Enzyme Inhibitors; Flufenamic Acid; Glioma; Humans; Imidazoles; Ion Transport; Masoprocol; Neoplasm Proteins; Nicardipine; Nimodipine; Nitrendipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Peptides; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Ryanodine; Thapsigargin; Tumor Cells, Cultured; Verapamil | 1999 |
Effect of nordihydroguaiaretic acid on intracellular Ca(2+) concentrations in C6 glioma cells.
Topics: Animals; Calcium; Calcium Signaling; Endoplasmic Reticulum; Extracellular Space; Glioma; Intracellular Membranes; Lipoxygenase; Masoprocol; Osmolar Concentration; Tumor Cells, Cultured; Type C Phospholipases | 2002 |
Effects of prostaglandin and leukotriene inhibitors on the growth of human glioma spheroids.
Topics: Arachidonic Acids; Dexamethasone; Glioma; Humans; Indomethacin; Ketoprofen; Leukotriene Antagonists; Lipoxygenase Inhibitors; Masoprocol; Mitosis; Prostaglandin Antagonists; Quinacrine; Tumor Cells, Cultured | 1990 |
Ultrastructural evidence for differentiation in a human glioblastoma cell line treated with inhibitors of eicosanoid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Cell Differentiation; Eicosanoids; Glial Fibrillary Acidic Protein; Glioma; Humans; Masoprocol; Microscopy, Electron; Tumor Cells, Cultured | 1990 |
Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Catechols; Cell Division; Cell Line; Cell Survival; DNA Replication; Glioma; Humans; Indomethacin; Kinetics; Lipoxygenase Inhibitors; Masoprocol; Pyrazoles; Rats; Tumor Cells, Cultured; Umbelliferones | 1989 |